Merops Switch to
Inhibitors

Peptidase

Family Clan SEARCHES BLAST
MEROPS SUBMISSIONS

Other
information

Literature for peptidase C03.007: human rhinovirus 2-type picornain 3C

Summary Alignment Tree Sequences Sequence features Distribution Structure Literature Substrates Pharma

(Topics flags: S Structure, T Target, P Specificity, I Inhibitor, E Expression, V Review. To select only the references relevant to a single topic, click the link above. See explanation.)

    2025
  1. Zhang,S., Zong,K., Ruan,J., Liu,X., Zhao,X., Zhang,Y., Hu,C. and Li,X.
    Discovery of non-covalent rhinovirus 3Cpro inhibitors by molecular docking, in vitro assays, molecular dynamics simulations and DFT analyses
    Front Pharmacol16, 1560571-1560571. PubMed  Europe PubMed DOI  I
    2. 2024
  2. Mei,M., Fan,X., Zhou,Y., Zhang,F., Zhang,G. and Yi,L.
    A combinatorial strategy for HRV 3C protease engineering to achieve the N-terminal free cleavage
    Int J Biol Macromol265, 131066-131066. PubMed  Europe PubMed DOI
  3. Tarumoto,S., Inoue,S., Yanagimoto,R. and Saitoh,T.
    Monitoring of enzymatic cleavage reaction of GST-fusion protein on biolayer interferometry sensor
    Biophys Physicobiol21, e210019-e210019. PubMed  Europe PubMed DOI
    4. 2021
  4. Abdelkader,E.H. and Otting,G.
    NT*-HRV3CP: An optimized construct of human rhinovirus 14 3C protease for high-yield expression and fast affinity-tag cleavage
    J Biotechnol325, 145-151. PubMed  Europe PubMed DOI
  5. Liu,C., Boland,S., Scholle,M.D., Bardiot,D., Marchand,A., Chaltin,P., Blatt,L.M., Beigelman,L., Symons,J.A., Raboisson,P., Gurard-Levin,Z.A., VanDyck,K. and Deval,J.
    Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development
    Antiviral Res187, 105020-105020. PubMed  Europe PubMed DOI  I
    6. 2020
  6. Fan,X., Li,X., Zhou,Y., Mei,M., Liu,P., Zhao,J., Peng,W., Jiang,Z.B., Yang,S., Iverson,B.L., Zhang,G. and Yi,L.
    Quantitative analysis of the substrate specificity of human rhinovirus 3C protease and exploration of its substrate recognition mechanisms
    ACS Chem Biol15, 63-73. PubMed  Europe PubMed DOI  P
  7. Smart,D., Filippi,I., Blume,C., Smalley,B., Davies,D. and McCormick,C.J.
    Rhinovirus 2A is the key protease responsible for instigating the early block to gene expression in infected cells
    J Cell Sci133, jcs232504-jcs232504. PubMed  Europe PubMed DOI
    8. 2019
  8. Kassem,A.F., Batran,R.Z., Abbas,E.M.H., Elseginy,S.A., Shaheen,M.N.F. and Elmahdy,E.M.
    New 4-phenylcoumarin derivatives as potent 3C protease inhibitors: design, synthesis, anti-HAV effect and molecular modeling
    Eur J Med Chem168, 447-460. PubMed  Europe PubMed DOI  I
  9. Xu,H., Wang,Q., Zhang,Z., Yi,L., Ma,L. and Zhai,C.
    A simplified method to remove fusion tags from a xylanase of Bacillus sp. HBP8 with HRV 3C protease
    Enzyme Microb Technol123, 15-20. PubMed  Europe PubMed DOI
    10. 2018
  10. Croft,S.N., Walker,E.J. and Ghildyal,R.
    Human rhinovirus 3C protease cleaves RIPK1, concurrent with caspase 8 activation
    Sci Rep8, 1569-1569. PubMed  Europe PubMed DOI
  11. Lotzerich,M., Roulin,P.S., Boucke,K., Witte,R., Georgiev,O. and Greber,U.F.
    Rhinovirus 3C protease suppresses apoptosis and triggers caspase-independent cell death
    Cell Death Dis9, 272-272. PubMed  Europe PubMed DOI
    12. 2016
  12. Kawatkar,S.P., Gagnon,M., Hoesch,V., Tiong-Yip,C., Johnson,K., Ek,M., Nilsson,E., Lister,T., Olsson,L., Patel,J. and Yu,Q.
    Design and structure-activity relationships of novel inhibitors of human rhinovirus 3C protease
    Bioorg Med Chem Lett26, 3248-3252. PubMed  Europe PubMed DOI  S  I
    13. 2015
  13. Jensen,L.M., Walker,E.J., Jans,D.A. and Ghildyal,R.
    Proteases of human rhinovirus: role in infection
    Methods Mol Biol1221, 129-141. PubMed  Europe PubMed DOI  V
  14. Jensen,L.M., Walker,E.J. and Ghildyal,R.
    A protocol to express and isolate HRV16 3C protease for use in protease assays
    Methods Mol Biol1221, 143-148. PubMed  Europe PubMed DOI  E
    15. 2014
  15. Feng,Y., Xu,Q., Yang,T., Sun,E., Li,J., Shi,D. and Wu,D.
    A novel self-cleavage system for production of soluble recombinant protein in Escherichia coli
    Protein Expr Purif99, 64-69. PubMed  Europe PubMed DOI
    16. 2013
  16. Raran-Kurussi,S., Tozser,J., Cherry,S., Tropea,J.E. and Waugh,D.S.
    Differential temperature dependence of tobacco etch virus and rhinovirus 3C proteases
    Anal Biochem436, 142-144. PubMed  Europe PubMed DOI
  17. Walker,E.J., Younessi,P., Fulcher,A.J., McCuaig,R., Thomas,B.J., Bardin,P.G., Jans,D.A. and Ghildyal,R.
    Rhinovirus 3C protease facilitates specific nucleoporin cleavage and mislocalisation of nuclear proteins in infected host cells
    PLoS ONE8, e71316-e71316. PubMed  Europe PubMed DOI
    18. 2012
  18. Wishart,D.S.
    Picornain 3C (human rhinovirus)
    [ISSN:978-0-12-407743-0]3, 2402-2406. DOI
    19. 2011
  19. Baxter,A., Chambers,M., Edfeldt,F., Edman,K., Freeman,A., Johansson,C., King,S., Morley,A., Petersen,J., Rawlins,P., Spadola,L., Thong,B., Poel,H.V. and Williams,N.
    Non-covalent inhibitors of rhinovirus 3C protease
    Bioorg Med Chem Lett21, 777-780. PubMed  Europe PubMed DOI  I
    20. 2009
  20. Barral,P.M., Sarkar,D., Fisher,P.B. and Racaniello,V.R.
    RIG-I is cleaved during picornavirus infection
    Virology391, 171-176. PubMed  Europe PubMed DOI
  21. Ghildyal,R., Jordan,B., Li,D., Dagher,H., Bardin,P.G., Gern,J.E. and Jans,D.A.
    Rhinovirus 3C protease can localize in the nucleus and alter active and passive nucleocytoplasmic transport
    J Virol83, 7349-7352. PubMed  Europe PubMed DOI
  22. Im,I., Lee,E.S., Choi,S.J., Lee,J.Y. and Kim,Y.C.
    Structure-activity relationships of heteroaromatic esters as human rhinovirus 3C protease inhibitors
    Bioorg Med Chem Lett19, 3632-3636. PubMed  Europe PubMed DOI  I
    23. 2008
  23. de Breyne,S., Bonderoff,J.M., Chumakov,K.M., Lloyd,R.E. and Hellen,C.U.
    Cleavage of eukaryotic initiation factor eIF5B by enterovirus 3C proteases
    Virology378, 118-122. PubMed  Europe PubMed DOI
    24. 2007
  24. Lao,X.Z. and Wu,W.T.
    Structure-based design of human rhinovirus 3C protease inhibitors
    Yao Wu Sheng Wu Ji Shu14, 218-220.  I
  25. Wanga,Q.M. and Chen,S.H.
    Human rhinovirus 3C protease as a potential target for the development of antiviral agents
    Curr Protein Pept Sci8, 19-27. PubMed  Europe PubMed DOI  V  T
    26. 2005
  26. Binford,S.L., Maldonado,F., Brothers,M.A., Weady,P.T., Zalman,L.S., Meador,J.W., III, Matthews,D.A. and Patick,A.K.
    Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor
    Antimicrob Agents Chemother49, 619-626. PubMed  Europe PubMed DOI  I
  27. Patick,A.K., Brothers,M.A., Maldonado,F., Binford,S., Maldonado,O., Fuhrman,S., Petersen,A., Smith,G.J., III, Zalman,L.S., Burns-Naas,L.A. and Tran,J.Q.
    In vitro antiviral activity and single-dose pharmacokinetics in humans of a novel, orally bioavailable inhibitor of human rhinovirus 3C protease
    Antimicrob Agents Chemother49, 2267-2275. PubMed  Europe PubMed DOI  I
    28. 2004
  28. Amineva,S.P., Aminev,A.G., Palmenberg,A.C. and Gern,J.E.
    Rhinovirus 3C protease precursors 3CD and 3CD' localize to the nuclei of infected cells
    J Gen Virol85, 2969-2979. PubMed  Europe PubMed DOI
  29. [YEAR:6-11-2004]Funkhouser,A.W., Kang,J.A., Tan,A., Li,J., Zhou,L., Abe,M.K., Solway,J. and Hershenson,M.B.
    Rhinovirus 16 3C protease induces interleukin-8 and granulocyte-macrophage colony-stimulating factor expression in human bronchial epithelial cells
    Pediatr Res55, 13-18. PubMed  Europe PubMed DOI
  30. Lall,M.S., Jain,R.P. and Vederas,J.C.
    Inhibitors of 3C cysteine proteinases from Picornaviridae
    Curr Top Med Chem4, 1239-1253. PubMed  Europe PubMed DOI  I
  31. Skern,T.
    Picornain 3C
    [ISSN:0-12-079610-4]2, 1353-1357.  V
  32. Wang,Q.M.
    Picornain 3C (human rhinovirus)
    [ISSN:0-12-079610-4]2, 1358-1361.  V
    33. 2003
  33. [YEAR:20-10-2003]Chen,S.H., Lamar,J., Victor,F., Snyder,N., Johnson,R., Heinz,B.A., Wakulchik,M. and Wang,Q.M.
    Synthesis and evaluation of tripeptidyl alpha-ketoamides as human rhinovirus 3C protease inhibitors
    Bioorg Med Chem Lett13, 3531-3536. PubMed  Europe PubMed DOI  I
  34. [YEAR:9-10-2003]Dragovich,P.S., Prins,T.J., Zhou,R., Johnson,T.O., Hua,Y., Luu,H.T., Sakata,S.K., Brown,E.L., Maldonado,F.C., Tuntland,T., Lee,C.A., Fuhrman,S.A., Zalman,L.S., Patick,A.K., Matthews,D.A., Wu,E.Y., Guo,M., Borer,B.C., Nayyar,N.K., Moran,T., Chen,L., Rejto,P.A., Rose,P.W., Guzman,M.C., Dovalsantos,E.Z., Lee,S., McGee,K., Mohajeri,M., Liese,A., Tao,J., Kosa,M.B., Liu,B., Batugo,M.R., Gleeson,J.P., Wu,Z.P., Liu,J., Meador,J.W., III and Ferre,R.A.
    Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 8. Pharmacological optimization of orally bioavailable 2-pyridone-containing peptidomimetics
    J Med Chem46, 4572-4585. PubMed  Europe PubMed DOI  I
    35. 2002
  35. [YEAR:11-4-2002]Dragovich,P.S., Prins,T.J., Zhou,R., Brown,E.L., Maldonado,F.C., Fuhrman,S.A., Zalman,L.S., Tuntland,T., Lee,C.A., Patick,A.K., Matthews,D.A., Hendrickson,T.F., Kosa,M.B., Liu,B., Batugo,M.R., Gleeson,J.P., Sakata,S.K., Chen,L., Guzman,M.C., Meador,J.W., III, Ferre,R.A. and Worland,S.T.
    Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 6. Structure-activity studies of orally bioavailable, 2-pyridone-containing peptidomimetics
    J Med Chem45, 1607-1623. PubMed  Europe PubMed DOI  S  I
  36. [YEAR:11-3-2002]Dragovich,P.S., Prins,T.J., Zhou,R., Johnson,T.O., Brown,E.L., Maldonado,F.C., Fuhrman,S.A., Zalman,L.S., Patick,A.K., Matthews,D.A., Hou,X., Meador,J.W., Ferre,R.A. and Worland,S.T.
    Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. Part 7: Structure-activity studies of bicyclic 2-pyridone-containing peptidomimetics
    Bioorg Med Chem Lett12, 733-738. PubMed  Europe PubMed DOI  I
    37. 2001
  37. [YEAR:24-9-2001]Tian,Q.P., Nayyar,N.K., Babu,S., Chen,L.J., Tao,J.H., Lee,S., Tibbetts,A., Moran,T., Liou,J., Guo,M. and Kennedy,T.P.
    An efficient synthesis of a key intermediate for the preparation of the rhinovirus protease inhibitor AG7088 via asymmetric dianionic cyanomethylation of N-Boc-L-(+)-glutamic acid dimethyl ester
    Tetrahedron Lett42, 6807-6809.  I
  38. [YEAR:22-10-2001]Webber,S.E., Marakovits,J.T., Dragovich,P.S., Prins,T.J., Zhou,R., Fuhrman,S.A., Patick,A.K., Matthews,D.A., Lee,C.A., Srinivasan,B., Moran,T., Ford,C.E., Brothers,M.A., Harr,J.E., Meador,J.W., III, Ferre,R.A. and Worland,S.T.
    Design and synthesis of irreversible depsipeptidyl human rhinovirus 3C protease inhibitors
    Bioorg Med Chem Lett11, 2683-2686. PubMed  Europe PubMed DOI  I
  39. Zhang,K.E., Hee,B., Lee,C.A., Liang,B. and Potts,B.C.
    Liquid chromatography-mass spectrometry and liquid chromatography-NMR characterization of in vitro metabolites of a potent and irreversible peptidomimetic inhibitor of rhinovirus 3C protease
    Drug Metab Dispos29, 729-734. PubMed  Europe PubMed  I
    40. 2000
  40. [YEAR:3-1-2000]Dragovich,P.S., Zhou,R., Webber,S.E., Prins,T.J., Kwok,A.K., Okano,K., Fuhrman,S.A., Zalman,L.S., Maldonado,F.C., Brown,E.L., Meador,J.W., III, Patick,A.K., Ford,C.E., Brothers,M.A., Binford,S.L., Matthews,D.A., Ferre,R.A. and Worland,S.T.
    Structure-based design of ketone-containing, tripeptidyl human rhinovirus 3C protease inhibitors
    Bioorg Med Chem Lett10, 45-48. PubMed  Europe PubMed DOI  I
  41. Zalman,L.S., Brothers,M.A., Dragovich,P.S., Zhou,R., Prins,T.J., Worland,S.T. and Patick,A.K.
    Inhibition of human rhinovirus-induced cytokine production by AG7088, a human rhinovirus 3C protease inhibitor
    Antimicrobial Agents Chemother44, 1236-1241. PubMed  Europe PubMed DOI  I
    42. 1999
  42. Dragovich,P.S., Zhou,R., Skalitzky,D.J., Fuhrman,S.A., Patick,A.K., Ford,C.E., Meador,J.W., III and Worland,S.T.
    Solid-phase synthesis of irreversible human rhinovirus 3C protease inhibitors. Part 1: Optimization of tripeptides incorporating N-terminal amides
    Bioorg Med Chem7, 589-598. PubMed  Europe PubMed DOI  I
  43. [YEAR:8-4-1999]Dragovich,P.S., Prins,T.J., Zhou,R., Fuhrman,S.A., Patick,A.K., Matthews,D.A., Ford,C.E., Meador,J.W., III, Ferre,R.A. and Worland,S.T.
    Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 3. Structure-activity studies of ketomethylene-containing peptidomimetics
    J Med Chem42, 1203-1212. PubMed  Europe PubMed DOI  I
  44. [YEAR:24-12-1999]Hill,R.D. and Vederas,J.C.
    Azodicarboxamides: a new class of cysteine proteinase inhibitor for hepatitis A virus and human rhinovirus 3C enzymes
    J Org Chem64, 9538-9546.  I
  45. [YEAR:15-2-1999]Kati,W.M., Sham,H.L., McCall,J.O., Montgomery,D.A., Wang,G.T., Rosenbrook,W., Miesbauer,L., Buko,A. and Norbeck,D.W.
    Inhibition of 3C protease from human rhinovirus strain 1B by peptidyl bromomethylketonehydrazides
    Arch Biochem Biophys362, 363-375. PubMed  Europe PubMed DOI  I
  46. [YEAR:28-9-1999]Matthews,D.A., Dragovich,P.S., Webber,S.E., Fuhrman,S.A., Patick,A.K., Zalman,L.S., Hendrickson,T.F., Love,R.A., Prins,T.J., Marakovits,J.T., Zhou,R., Tikhe,J., Ford,C.E., Meador,J.W., Ferre,R.A., Brown,E.L., Binford,S.L., Brothers,M.A., DeLisle,D.M. and Worland,S.T.
    Structure-assisted design of mechanism-based irreversible inhibitors of human rhinovirus 3C protease with potent antiviral activity against multiple rhinovirus serotypes
    Proc Natl Acad Sci U S A96, 11000-11007. PubMed  Europe PubMed DOI  I
  47. Patick,A.K., Binford,S.L., Brothers,M.A., Jackson,R.L., Ford,C.E., Diem,M.D., Maldonado,F., Dragovich,P.S., Zhou,R., Prins,T.J., Fuhrman,S.A., Meador,J.W., Zalman,L.S., Matthews,D.A. and Worland,S.T.
    In vitro antiviral activity of AG7088, a potent inhibitor of human rhinovirus 3C protease
    Antimicrobial Agents Chemother43, 2444-2450. PubMed  Europe PubMed  I
  48. Wang,Q.M.
    Protease inhibitors as potential antiviral agents for the treatment of picornaviral infections
    Prog Drug Res52, 197-219. PubMed  Europe PubMed  T
    49. 1998
  49. [YEAR:16-7-1998]Dragovich,P.S., Webber,S.E., Babine,R.E., Fuhrman,S.A., Patick,A.K., Matthews,D.A., Reich,S.H., Marakovits,J.T., Prins,T.J., Zhou,R., Tikhe,J., Littlefield,E.S., Bleckman,T.M., Wallace,M.B., Little,T.L., Ford,C.E., Meador,J.W., III, Ferre,R.A., Brown,E.L., Binford,S.L., DeLisle,D.M. and Worland,S.T.
    Structure-based design, synthesis, and biological evaluation of irreversible human rhinovirus 3C protease inhibitors. 2. Peptide structure-activity studies
    J Med Chem41, 2819-2834. PubMed  Europe PubMed DOI  I
  50. [YEAR:2-7-1998]Kong,J.S., Venkatraman,S., Furness,K., Nimkar,S., Shepherd,T.A., Wang,Q.M., Aube,J. and Hanzlik,R.P.
    Synthesis and evaluation of peptidyl Michael acceptors that inactivate human rhinovirus 3C protease and inhibit virus replication
    J Med Chem41, 2579-2587. PubMed  Europe PubMed DOI  I
    51. 1997
  51. Ryan,M.D. and Flint,M.
    Virus-encoded proteinases of the picornavirus super-group
    J Gen Virol78, 699-723. PubMed  Europe PubMed
    52. 1996
  52. Heinz,B.A., Tang,J., Labus,J.M., Chadwell,F.W., Kaldor,S.W. and Hammond,M.
    Simple in vitro translation assay to analyze inhibitors of rhinovirus proteases
    Antimicrobial Agents Chemother40, 267-270. PubMed  Europe PubMed
    53. 1995
  53. Sham,H.L., Rosenbrook,W., Kati,W., Betebenner,D.A., Wideburg,N.E., Saldivar,A., Plattner,J.J. and Norbeck,D.W.
    Potent inhibitor of the human rhinovirus (HRV) 3C protease containing a backbone modified glutamine
    Chem Soc J [Perkin 1]1, 1081-1082.  I
    54. 1994
  54. Matthews,D.A., Smith,W.W., Ferre,R.A., Condon,B., Budahazi,G., Sisson,W., Villafranca,J.E., Janson,C.A., McElroy,H.E., Gribskov,C.L. and Worland,S.
    Structure of human rhinovirus 3C protease reveals a trypsin-like polypeptide fold, RNA-binding site, and means for cleaving precursor polyprotein
    Cell77, 761-771. PubMed  Europe PubMed DOI  S
    55. 1992
  55. Leong,L.E.C., Walker,P.A. and Porter,A.G.
    Efficient expression and purification of a protease from the common cold virus, human rhinovirus type-14
    J Cryst Growth122, 246-252.  E
    56. 1991
  56. Hopkins,J.L., Betageri,R., Cohen,K.A., Emmanuel,M.J., Joseph,C.R., Bax,P.M., Pallai,P.V. and Skoog,M.T.
    Rhinovirus 3C protease catalyzes efficient cleavage of a fluorescein-labeled peptide affording a rapid and robust assay
    J Biochem Biophys Methods23, 107-113. PubMed  Europe PubMed DOI  P
  57. Singh,S.B., Cordingley,M.G., Ball,R.G., Smith,J.L., Dombrowski,A.W. and Goetz,M.A.
    Structure and stereochemistry of thysanone: a novel human rhinovirus 3C-protease inhibitor from Thysanophora penicilloides
    Tetrahedron Lett32, 5279-5282. DOI  I
    58. 1990
  58. Cheah,K.C., Leong,L.E. and Porter,A.G.
    Site-directed mutagenesis suggests close functional relationship between a human rhinovirus 3C cysteine protease and cellular trypsin-like serine proteases
    J Biol Chem265, 7180-7187. PubMed  Europe PubMed
    59. 1989
  59. Knott,J.A., Orr,D.C., Montgomery,D.S., Sullivan,C.A. and Weston,A.
    The expression and purification of human rhinovirus protease 3C
    Eur J Biochem182, 547-555. PubMed  Europe PubMed
    60. 1988
  60. Krausslich,H.G. and Wimmer,E.
    Viral proteinases
    Annu Rev Biochem57, 701-754. PubMed  Europe PubMed DOI
    61. 1984
  61. Blinov,V.M., Gorbalenia,A.E. and Donchenko,A.P.
    [Structural similarity of poliovirus cysteine proteinase P3-7c and cellular serine proteinase of trypsin]
    Dokl Akad Nauk SSSR279, 502-505. PubMed  Europe PubMed

feedback
Page created 8-September-2023

EMBL-EBI logo

© 2025 EBI
Terms of use